Auditor21 May 2026, 07:31 pm
Suraksha Diagnostic Reappoints S Chhaparia as Cost Auditor
AI Summary
Suraksha Diagnostic Ltd has re-appointed M/s S Chhaparia & Associates as Cost Auditor for the financial year ending March 31, 2026. This decision was made during a Board of Directors meeting on May 21, 2026, where the board also approved the audited financial results for the same period and recommended a dividend of ₹0.50 per equity share. The appointment is subject to shareholder ratification at the upcoming 21st Annual General Meeting (AGM).
Key Highlights
- S Chhaparia & Associates re-appointed as Cost Auditor for FY 2026-27, subject to shareholder approval.
- Board approved audited financial results for the quarter and year ended March 31, 2026.
- Dividend of ₹0.50 per share recommended for FY 2025-26, pending shareholder approval.
- Suresh Surana & Associates LLP appointed as Internal Auditor for FY 2026-27.
Price Impact
More from SURAKSHA